Protective role of interleukin-19 gene polymorphisms in patients with ulcerative colitis

Human Immunology

Volumn 72, Issue 11, 2011, Pages 1029-1032

  Yamamoto Furusho, Jesús K ^a   Álvarez León, Edith ^b   Fragoso, José Manuel ^b   Gozalishvilli, Anna ^b   Vallejo, Maite ^b   Vargas Alarcón, Gilberto ^b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Genetic susceptibility; IL 19 polymorphism; Mexican; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; INFLIXIMAB; INTERLEUKIN 19; STEROID;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNOMODULATION; INTERLEUKINS; MALE; MEXICO; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK;

EID: 80054095019     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.08.013     Document Type: Article

References (33)

1. Yamamoto-Furusho J.K., Uscanga L.F., Vargas-Alarcón G., Ruiz-Morales J.A., Higuera L., Cutiño T., et al. Clinical and genetic heterogeneity in Mexican patients with ulcerative colitis. Hum Immunol 2003, 64:119-123.
2. Neuman M.G. Immune dysfunction in inflammatory bowel disease. Transl Res 2007, 149:173-186.
3. Xavier R.J., Podolsky D.K. Unraveling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434.
4. Juyal G., Prasad P., Senapati S., Midha V., Sood A., Amre D., et al. An investigation of genome-wide studies reported susceptibility loci for ulcerative colitis shows limited replication in north Indians. PLoS ONE 2011, 6:e16565.
5. Franke A., McGovern D.P., Barrett J.C., Wang K., Radford-Smith G.L., Ahmad T., et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010, 42:1118-1125.
6. McGovern D.P., Gardet A., Törkvist L., Goyette P., Essers J., Taylor K.D., et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet 2010, 42:332-337.
7. Franke A., Balschun T., Sina C., Ellinghaus D., Häsler R., Mayr G., et al. Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL). Nat Genet 2010, 42:292-294.
8. Blumberg H., Conklin D., Xu W.F., Grossmann A., Brender T., Carollo S., et al. Interleukin 20: Discovery, receptor identification, and role in epidermal function. Cell 2001, 104:9-19.
9. Dumoutier L., Louahed J., Renauld J.C. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol 2000, 164:1814-1819.
10. Gallagher G., Dickensheets H., Eskdale J., Izotova L.S., Mirochnitchenko O.V., Peat J.D., et al. Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun 2000, 1:442-450.
11. Jiang H., Lin J.J., Su Z.Z., Goldstein N.I., Fisher P.B. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 1995, 11:2477-2486.
12. Knappe A., Hör S., Wittmann S., Fickenscher H. Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpes virus Saimiri. J Virol 2000, 74:3881-3887.
13. Gallagher G., Eskdale J., Jordan W., Peat J., Campbell J., Boniotto M., et al. Human interleukin-19 and its receptor: A potential role in the induction of Th2 responses. Int Immunopharmacol 2004, 4:615-626.
14. Dumoutier L., Leemans C., Lejeune D., Kotenko S.V., Renauld J.C. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol 2001, 167:3545-3549.
15. Kunz S., Wolk K., Witte E., Witte K., Doecke W.D., Volk H.D., et al. Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs. Exp Dermatol 2006, 15:991-1004.
16. Johanneson B., Lima G., von Salomé J., Alarcón-Segovia D., Alarcón-Riquelme M.E. Collaborative Group on the Genetics of SLE, The BIOMED II Collaboration on the Genetics of SLE and Sjögren's syndrome. A major susceptibility locus for systemic lupus erythematosus maps to chromosome 1q31. Am J Hum Genet 2002, 71:1060-1071.
17. Martinez A., Pascual M., Pascual-Salcedo D., Balsa A., Martin J., de la Concha E.G. Genetic polymorphisms in Spanish rheumatoid arthritis patients: An association and linkage study. Genes Immun 2003, 4:117-121.
18. Kods S., Kingo K., Rätsep R., Karelson M., Silm H., Vasar E. Combined haplotype analysis of the interleukin-19 and 20 genes: Relationship to plaque-type psoriasis. Genes Immun 2004, 5:662-667.
19. Henriksen M., Jahnsen J., Lygren I., Sauar J., Kjellevold O., Schulz T., et al. Ulcerative colitis and clinical course: Results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowel Dis 2006, 12:543-550.
20. Miller S.A., Dykes D.D., Polesky H.F. A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215-1220.
21. Franke A., Balschun T., Karlsen T.H., Sventoraityte J., Nikolaus S., Mayr G., et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 2008, 40:1319-1323.
22. Mignone F., Gissi C., Liuni S., Pesole G. Untranslated regions of mRNAs. Genome Biol 2002, 3:1-10.
23. Bashirullah A., Cooperstock R.L., Lipshitz H.D. Spatial and temporal control of RNA stability. Proc Natl Acad Sci U S A 2001, 98:7025-7028.
24. Jordan W.J., Eskdale J., Boniotto M., Lennon G.P., Peat J., Campbell J.D., et al. Human IL-19 regulates immunity through auto-induction of IL-19 and production of IL-10. Eur J Immunol 2005, 35:1576-1582.
25. Wolk K., Kunz S., Asadullah K., Sabat R. Immune cells as sources and targets of the IL-10 family members?. J Immunol 2002, 168:5397-5402.
26. Fickenscher H., Hör S., Küpers H., Knappe A., Wittmann S., Sticht H. The interluukin-10 family of cytokines. Trends Immunol 2002, 23:89-96.
27. Nagalakshmi M.L., Murphy E., McClanahan T., de Waal Malefyt R. Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization. Int Immunopharmacol 2004, 4:577-592.
28. Azuma Y.T., Matsuo Y., Kuwamura M., Yancopoulos G.D., Valenzuela D.M., Murphy A.J., et al. Interleukin 19 protects mice from innate-mediated colonic inflammation. Inflamm Bowel Dis 2010, 16:1017-1028.
29. Liao S.C., Cheng Y.C., Wang Y.C., Wang C.W., Yang S.M., Yu C.K., et al. IL-19 induced Th2 cytokines and was up-regulated in asthma patients. J Immunol 2004, 173:6712-6718.
30. Li H.H., Lin Y.C., Chen P.J., Hsiao C.H., Lee J.Y., Chen W.C., et al. Interleukin-19 upregulates keratinocyte growth factor and is associated with psoriasis. Br J Dermatol 2005, 153:591-595.
31. Sa S.M., Valdez P.A., Wu J., Jung K., Zhong F., Hall L., et al. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J Immunol 2007, 178:2229-2240.
32. Hsing C.H., Hsu C.C., Chen W.Y., Chang L.Y., Hwang J.C., Chang M.S. Expression of IL-19 correlates with Th2 cytokines in uraemic patients. Nephrol Dial Transplant 2007, 22:2230-2238.
33. Yamamoto-Furusho J.K., Uscanga L.F., Vargas-Alarcón G., Rodríguez-Pérez J.M., Zuñiga J., Granados J. Polymorphisms in the promoter region of tumor necrosis factor alpha (TNF-alpha) and the HLA-DRB1 locus in Mexican mestizo patients with ulcerative colitis. Immunol Lett 2004, 95:31-35.